A major move is in the offing as Health Catalyst Inc (HCAT) market cap hits 407.58 million

Health Catalyst Inc (NASDAQ: HCAT) kicked off on Tuesday, down -4.40% from the previous trading day, before settling in for the closing price of $7.28. Over the past 52 weeks, HCAT has traded in a range of $6.60-$14.37.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Healthcare Sector giant saw their annual sales surged by 21.79% over the last five years. While this was happening, its average annual earnings per share was recorded 113.27%. With a float of $55.71 million, this company’s outstanding shares have now reached $58.30 million.

The firm has a total of 1300 workers. Let’s measure their productivity.

Health Catalyst Inc (HCAT) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 4.87%, while institutional ownership is 86.80%. The most recent insider transaction that took place on Mar 15 ’24, was worth 15,648. In this transaction Chief People Officer of this company sold 2,005 shares at a rate of $7.80, taking the stock ownership to the 128,231 shares. Before that another transaction happened on Feb 27 ’24, when Company’s Chief Executive Officer bought 26,200 for $7.81, making the entire transaction worth $204,525. This insider now owns 1,172,623 shares in total.

Health Catalyst Inc (HCAT) Earnings and Forecasts

In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported $0.02 earnings per share (EPS), higher than consensus estimate (set at $0) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 113.27% per share during the next fiscal year.

Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators

Take a look at Health Catalyst Inc’s (HCAT) current performance indicators. Last quarter, stock had a quick ratio of 4.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.38.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.50 in one year’s time.

Technical Analysis of Health Catalyst Inc (HCAT)

Analysing the last 5-days average volume posted by the [Health Catalyst Inc, HCAT], we can find that recorded value of 0.49 million was lower than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 6.83%. Additionally, its Average True Range was 0.39.

During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 7.48%, which indicates a significant increase from 3.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.65% in the past 14 days, which was lower than the 64.29% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $8.81, while its 200-day Moving Average is $9.85. Now, the first resistance to watch is $7.18. This is followed by the second major resistance level at $7.41. The third major resistance level sits at $7.54. If the price goes on to break the first support level at $6.82, it is likely to go to the next support level at $6.69. Should the price break the second support level, the third support level stands at $6.46.

Health Catalyst Inc (NASDAQ: HCAT) Key Stats

The company with the Market Capitalisation of 407.58 million has total of 58,563K Shares Outstanding. Its annual sales at the moment are 295,940 K in contrast with the sum of -118,150 K annual income. Company’s last quarter sales were recorded 75,080 K and last quarter income was -30,310 K.